Luigi De Masi

Dr. Luigi De Masi

National Research Council (CNR), Institute of Biosciences and Bioresources (IBBR), Via Università 133, 80055 Portici (Naples), Italy
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2010 in Molecular Plant Pathology
Verified
Journal Article
Closed access
PDF file
MTMarina Tucci
Marina Tucci
MRMichelina Ruocco
Michelina Ruocco
LMLuigi De Masi
Luigi De Masi
MPMonica De Palma
Monica De Palma
MLMatteo Lorito
Matteo Lorito

1 February 2025 in Molecules
Verified
Journal Article
Open access
PDF file
LCLucia Capasso
Lucia Capasso
LMLuigi De Masi
Luigi De Masi
CSCarmina Sirignano
Carmina Sirignano
Viviana MarescaViviana Maresca
Viviana Maresca
Adriana BasileAdriana Basile
Adriana Basile
PBPaola Bontempo
Paola Bontempo
Epigallocatechin gallate (EGCG), the predominant catechin in green tea, comprises approximately 50% of its total polyphenol content and has garnered widespread recognition for its significant therapeutic potential. As the principal bioactive component of Camellia sinensis, EGCG is celebrated for its potent antioxidant, anti-inflammatory, cardioprotective, and antitumor properties. The bioavailability and metabolism of EGCG within the gut microbiota underscore its systemic effects, as it is absorbed in the intestine, metabolized into bioactive compounds, and transported to target organs. This compound has been shown to influence key physiological pathways, particularly those related to lipid metabolism and inflammation, offering protective effects against a variety of diseases. EGCG’s ability to modulate cell signaling pathways associated with oxidative stress, apoptosis, and immune regulation highlights its multifaceted role in health promotion. Emerging evidence underscores EGCG’s therapeutic potential in preventing and managing a range of chronic conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. Given the growing prevalence of lifestyle-related diseases and the increasing interest in natural compounds, EGCG presents a promising avenue for novel therapeutic strategies. This review aims to summarize current knowledge on EGCG, emphasizing its critical role as a versatile natural bioactive agent with diverse clinical applications. Further exploration in both experimental and clinical settings is essential to fully unlock its therapeutic potential.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
CQCristina Quispe
Cristina Quispe
CCCarla Marina Salgado Castillo
Carla Marina Salgado Castillo
RCRodrigo Caroca
Rodrigo Caroca
MLMarco A. Lazo-Vélez
Marco A. Lazo-Vélez
William C. ChoWilliam C. Cho
William C. Cho
Ellagic acid (EA) is a bioactive polyphenolic compound naturally occurring as secondary metabolite in many plant taxa. EA content is considerable in pomegranate (Punica granatum L.) and in wood and bark of some tree species. Structurally, EA is a dilactone of hexahydroxydiphenic acid (HHDP), a dimeric gallic acid derivative, produced mainly by hydrolysis of ellagitannins, a widely distributed group of secondary metabolites. EA is attracting attention due to its antioxidant, anti‐inflammatory, antimutagenic, and antiproliferative properties. EA displayed pharmacological effects in various in vitro and in vivo model systems. Furthermore, EA has also been well documented for its antiallergic, antiatherosclerotic, cardioprotective, hepatoprotective, nephroprotective, and neuroprotective properties. This review reports on the health‐promoting effects of EA, along with possible mechanisms of its action in maintaining the health status, by summarizing the literature related to the therapeutic potential of this polyphenolic in the treatment of several human diseases.

27 January 2006 in European Food Research and Technology
Verified
Journal Article
Closed access
PDF file
LMLuigi De Masi
Luigi De Masi
PSPietro Siviero
Pietro Siviero
CECastrese Esposito
Castrese Esposito
DCDomenico Castaldo
Domenico Castaldo
FSFrancesco Siano
Francesco Siano
BLBruna Laratta
Bruna Laratta

1 December 2015 in Journal of Functional Foods
Verified
Journal Article
Open access
PBPaola Bontempo
Paola Bontempo
LMLuigi De Masi
Luigi De Masi
Vincenzo CarafaVincenzo Carafa
Vincenzo Carafa
DRDaniela Rigano
Daniela Rigano
LSLucia Scisciola
Lucia Scisciola
Lucia AltucciLucia Altucci
Lucia Altucci
The action of anthocyanins contained in the Vitelotte potato (Solanum tuberosum L.) in both breast and haematological cancers were investigated. The biomedical activities of anthocyanin extract derived from the Vitelotte cultivar were determined. Molecular genotyping was performed to properly identify this outstanding genotype in comparison to other potato varieties and to promote the utilization of this genetic resource by plant breeders. Furthermore, cellular and molecular characterization of the action of anthocyanin extract in cancer cells revealed that modulation of cell cycle regulators occurs upon treatment. As well as inducing apoptotic players such as TRAIL in cancer systems, anthocyanin extract inhibited Akt-mTOR signalling thereby inducing maturation of acute myeloid leukaemia cells. These results are of interest in view of the impact on food consumption and as functional food components on potential cancer treatment and prevention

4 December 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
BSBernardina Scafuri
Bernardina Scafuri
PBPaola Bontempo
Paola Bontempo
Lucia AltucciLucia Altucci
Lucia Altucci
LMLuigi De Masi
Luigi De Masi
AFAngelo Facchiano
Angelo Facchiano
Histone modifications through acetylation are fundamental for remodelling chromatin and consequently activating gene expression. The imbalance between acetylation and deacetylation activity causes transcriptional dysregulation associated with several disorders. Flavones, small molecules of plant origin, are known to interfere with class I histone deacetylase (HDAC) enzymes and to enhance acetylation, restoring cell homeostasis. To investigate the possible physical interactions of flavones on human HDAC1 and 2, we carried out in silico molecular docking simulations. Our data have revealed how flavone, and other two flavones previously investigated, i.e., apigenin and luteolin, can interact as ligands with HDAC1 and 2 at the active site binding pocket. Regulation of HDAC activity by dietary flavones could have important implications in developing epigenetic therapy to regulate the cell gene expression.